Table 6.
Association between monoclonal gammopathies and direct kidney injury.
| Monoclonal gammopathy | Odds ratio (95% CI)∗ | P value |
|---|---|---|
| MM | 47.5 (13.7–164.9) | <0.001 |
| NHL | 2.1 (0.6–7.2) | 0.194 |
| SMM | 0.5 (0.1–3) | 0.5 |
| MGUS | 0.01 (0.005–0.04) | <0.001 |
| HL | — | 0.153 |
HL, Hodgkin lymphoma; NHL, non-Hodgkin lymphoma; MGUS, monoclonal gammopathy of indeterminate significance; MM, multiple myeloma; SMM, smoldering multiple myeloma. AL amyloidosis was not tested because the pathogenesis of amyloidosis depends on a proven direct kidney injury due to the deposition of light chain within the renal parenchyma. P value for MGUS was statistically but not clinically significant. The protective effect of MGUS in developing kidney disease is not applicable in this context.